Trademark applications and grants for Optiscan Biomedical Corp. Optiscan Biomedical Corp has 17 trademark applications. The latest application filed is for "OPTIZYMER"
Patent Application | Date |
---|---|
FLUID COMPONENT ANALYSIS SYSTEM AND METHOD FOR GLUCOSE MONITORING AND CONTROL 20200390974 - 16/859886 Rule; Peter | 2020-12-17 |
FLUID ANALYSIS SYSTEM 20200383620 - 16/878535 Lim; Eugene ;   et al. | 2020-12-10 |
AUTOMATED FLUID ANALYSIS USING TUNABLE OPTICAL SOURCES 20200355605 - 16/810636 Causey, III; James D. | 2020-11-12 |
FLUID HANDLING CASSETTE 20200352494 - 16/798208 Gable; Jennifer H. ;   et al. | 2020-11-12 |
BODILY FLUID COMPOSITION ANALYZER WITH DISPOSABLE CASSETTE 20200352493 - 16/788671 Gable; Jennifer H. ;   et al. | 2020-11-12 |
NCAGE Code | 5EMS3 | OPTISCAN BIOMEDICAL CORPORATION |
CAGE Code | 5EMS3 | OPTISCAN BIOMEDICAL CORPORATION |
SEC | 0000946340 | OPTISCAN BIOMEDICAL CORP of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.